dc.contributor.advisor | | |
dc.contributor.advisor | | |
dc.contributor.author | Schöttker, Ben | |
dc.contributor.author | Rathmann, Wolfgang | |
dc.contributor.author | Herder, Christian | |
dc.contributor.author | Thorand, Barbara | |
dc.contributor.author | Wilsgaard, Tom | |
dc.contributor.author | Njølstad, Inger | |
dc.contributor.author | Siganos, Galatios | |
dc.contributor.author | Mathiesen, Ellisiv B. | |
dc.contributor.author | Saum, Kai-Uwe | |
dc.contributor.author | Peasey, Anne | |
dc.contributor.author | Feskens, Edith J.M. | |
dc.contributor.author | Boffetta, Paolo | |
dc.contributor.author | Trichopoulou, Antonia | |
dc.contributor.author | Kuulasmaa, Kari | |
dc.contributor.author | Kee, Frank | |
dc.contributor.author | Brenner, Hermann | |
dc.date.accessioned | 2017-02-23T09:22:05Z | |
dc.date.available | 2017-02-23T09:22:05Z | |
dc.date.issued | 2016-02-11 | |
dc.description.abstract | Background:<br>To determine the shape of the associations of HbA1c with mortality and cardiovascular outcomes in
non-diabetic individuals and explore potential explanations.<br>
Methods:<br> The associations of HbA1c with all-cause mortality, cardiovascular mortality and primary cardiovascular
events (myocardial infarction or stroke) were assessed in non-diabetic subjects ≥50 years from six population-based
cohort studies from Europe and the USA and meta-analyzed. Very low, low, intermediate and increased HbA1c were
defined as <5.0, 5.0 to <5.5, 5.5 to <6.0 and 6.0 to <6.5 % (equals <31, 31 to <37, 37 to <42 and 42 to <48 mmol/mol),
respectively, and low HbA1c was used as reference in Cox proportional hazards models.<br>
Results:<br>Overall, 6,769 of 28,681 study participants died during a mean follow-up of 10.7 years, of whom 2,648 died of
cardiovascular disease. Furthermore, 2,493 experienced a primary cardiovascular event. A linear association with primary
cardiovascular events was observed. Adjustment for cardiovascular risk factors explained about 50 % of the excess risk
and attenuated hazard ratios (95 % confidence interval) for increased HbA1c to 1.14 (1.03–1.27), 1.17 (1.00–1.37) and
1.19 (1.04–1.37) for all-cause mortality, cardiovascular mortality and cardiovascular events, respectively. The six cohorts
yielded inconsistent results for the association of very low HbA1c levels with the mortality outcomes and the pooled
effect estimates were not statistically significant. In one cohort with a pronounced J-shaped association of HbA1c levels
with all-cause and cardiovascular mortality (NHANES), the following confounders of the association of very low HbA1c
levels with mortality outcomes were identified: race/ethnicity; alcohol consumption; BMI; as well as biomarkers of iron
deficiency anemia and liver function. Associations for very low HbA1c levels lost statistical significance in this cohort
after adjusting for these confounders.<br>Conclusions:<br> A linear association of HbA1c levels with primary cardiovascular events was observed. For cardiovascular
and all-cause mortality, the observed small effect sizes at both the lower and upper end of HbA1c distribution do not
support the notion of a J-shaped association of HbA1c levels because a certain degree of residual confounding needs
to be considered in the interpretation of the results.<br>
Keywords:<br> Glycated hemoglobin, Cardiovascular disease, Myocardial infarction, Stroke, Mortality, Cohort study, Meta-analysis | en_US |
dc.description.sponsorship | This analysis was part of the CHANCES project funded in the FP7 framework programme of DG-RESEARCH in the European Commission (grant no. 242244) and additional funding was obtained from the German Research Foundation (DFG; grant no. 616604). Further funding sources of participating cohorts are listed in the Additional file 1. (see <a href=http://dx.doi.org/10.1186/s12916-016-0570-1>doi: 10.1186/s12916-016-0570-1</a>) | en_US |
dc.description | Source: <a href=http://dx.doi.org/10.1186/s12916-016-0570-1>doi: 10.1186/s12916-016-0570-1</a> | en_US |
dc.identifier.citation | Schöttker B, Rathmann W, Herder C, Thorand B, Wilsgaard T, Njølstad i, Siganos G, Mathiesen EB, Saum K, Peasey A, Feskens EJ, Boffetta P, Trichopoulou A, Kuulasmaa K, Kee F, Brenner H. HbA1c levels in non-diabetic older adults - No J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confoundersin a meta-analysis of individual participant data from six cohort studies. BMC Medicine. 2016;14:26:1-17 | en_US |
dc.identifier.cristinID | FRIDAID 1419014 | |
dc.identifier.doi | 10.1186/s12916-016-0570-1 | |
dc.identifier.issn | 1741-7015 | |
dc.identifier.uri | https://hdl.handle.net/10037/10347 | |
dc.language.iso | eng | en_US |
dc.publisher | BioMed Central | |
dc.relation.journal | BMC Medicine | |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801 | en_US |
dc.subject | VDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801 | en_US |
dc.title | HbA1c levels in non-diabetic older adults - No J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confoundersin a meta-analysis of individual participant data from six cohort studies | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |